ArticlePharmacogenomics and personalized medicine2018

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients.

Nadica Matevska-Geshkovska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.